English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1855]
News [2824]
Articles [214]
Editorials [1]
Conferences [142]
elearning [13]
Social inequalities widen after a breast cancer
Social inequalities widen after a breast cancer
New global research aims to improve survival rates for pancreatic cancer patients
New global research aims to improve survival rates for pancreatic cancer patients
Research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
Research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: Research group completes first trial of Black patients with early-stage breast cancer
ASCO 2024: Research group completes first trial of Black patients with early-stage breast cancer
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal...
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung...
<1…2627282930…283>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top